Claudia Lindemann

830 total citations
19 papers, 370 citations indexed

About

Claudia Lindemann is a scholar working on Molecular Biology, Infectious Diseases and Spectroscopy. According to data from OpenAlex, Claudia Lindemann has authored 19 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Infectious Diseases and 3 papers in Spectroscopy. Recurrent topics in Claudia Lindemann's work include SARS-CoV-2 and COVID-19 Research (3 papers), Advanced Proteomics Techniques and Applications (3 papers) and Cancer Research and Treatments (2 papers). Claudia Lindemann is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Advanced Proteomics Techniques and Applications (3 papers) and Cancer Research and Treatments (2 papers). Claudia Lindemann collaborates with scholars based in Germany, United States and United Kingdom. Claudia Lindemann's co-authors include Helmut E. Meyer, Katrin Marcus, Lars I. Leichert, Jan Arends, Franz Narberhaus, Dirk Wolters, Jan Diekmann, Rani S. Sellers, Cynthia M. Rohde and Mark Cutler and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Claudia Lindemann

19 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Lindemann Germany 12 212 54 49 45 42 19 370
Wenguang Shao United States 12 294 1.4× 52 1.0× 175 3.6× 20 0.4× 9 0.2× 19 463
Christien Kluwe United States 8 205 1.0× 40 0.7× 38 0.8× 14 0.3× 7 0.2× 10 400
Delphine Flatters France 11 417 2.0× 23 0.4× 6 0.1× 47 1.0× 7 0.2× 27 530
Thomas Hesson United States 12 395 1.9× 17 0.3× 22 0.4× 74 1.6× 4 0.1× 16 687
Agnès M. Jaulent United Kingdom 12 397 1.9× 45 0.8× 8 0.2× 35 0.8× 4 0.1× 15 539
Halina Mikolajek United Kingdom 15 336 1.6× 52 1.0× 20 0.4× 53 1.2× 2 0.0× 29 532
Binghua Shen United States 10 403 1.9× 21 0.4× 36 0.7× 11 0.2× 4 0.1× 13 502
Max V. Ranall Australia 11 278 1.3× 40 0.7× 13 0.3× 14 0.3× 3 0.1× 13 688
Sayantani Chatterjee Australia 15 263 1.2× 124 2.3× 41 0.8× 81 1.8× 4 0.1× 29 498

Countries citing papers authored by Claudia Lindemann

Since Specialization
Citations

This map shows the geographic impact of Claudia Lindemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Lindemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Lindemann more than expected).

Fields of papers citing papers by Claudia Lindemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Lindemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Lindemann. The network helps show where Claudia Lindemann may publish in the future.

Co-authorship network of co-authors of Claudia Lindemann

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Lindemann. A scholar is included among the top collaborators of Claudia Lindemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Lindemann. Claudia Lindemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Türeci, Özlem, et al.. (2024). Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data. Human Vaccines & Immunotherapeutics. 20(1). 2315659–2315659. 9 indexed citations
2.
Pather, Shanti, Andrew Finlayson, Alexander Muik, et al.. (2024). A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine. Vaccine. 42(22). 126165–126165. 1 indexed citations
3.
Rohde, Cynthia M., Claudia Lindemann, Rani S. Sellers, et al.. (2023). Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines. Vaccines. 11(2). 417–417. 17 indexed citations
4.
Papadopoulos, Kyriakos P., Mustapha Tehfé, Albiruni Ryan Abdul Razak, et al.. (2023). A phase I/II dose escalation and expansion trial to evaluate safety and preliminary efficacy of BNT141 in patients with claudin-18.2-positive solid tumors.. Journal of Clinical Oncology. 41(16_suppl). TPS2670–TPS2670. 11 indexed citations
5.
Bähr-Mahmud, Hayat, Christiane Stadler, Claudia Lindemann, et al.. (2023). Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody. OncoImmunology. 12(1). 2255041–2255041. 16 indexed citations
6.
Yap, Timothy A., Kyriakos P. Papadopoulos, Elena Garralda, et al.. (2023). A phase I/II dose escalation trial with expansion cohorts to evaluate safety and preliminary efficacy of BNT142 in patients with prospectively confirmed claudin 6-positive solid tumors.. Journal of Clinical Oncology. 41(16_suppl). TPS2669–TPS2669. 8 indexed citations
7.
Bowman, Christopher, Sarah N. Campion, Gregg D. Cappon, et al.. (2021). Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine. Reproductive Toxicology. 103. 28–35. 55 indexed citations
8.
Arends, Jan, Claudia Lindemann, Katalin Barkovits, et al.. (2019). Intricate Crosstalk Between Lipopolysaccharide, Phospholipid and Fatty Acid Metabolism in Escherichia coli Modulates Proteolysis of LpxC. Frontiers in Microbiology. 9. 3285–3285. 39 indexed citations
9.
Lindemann, Claudia, et al.. (2018). Next-Generation Trapping of Protease Substrates by Label-Free Proteomics. Methods in molecular biology. 1841. 189–206. 3 indexed citations
10.
Arends, Jan, et al.. (2018). An Integrated Proteomic Approach Uncovers Novel Substrates and Functions of the Lon Protease in Escherichia coli. PROTEOMICS. 18(13). e1800080–e1800080. 23 indexed citations
11.
Flaxman, Amy, Pauline M. van Diemen, Yuko Yamaguchi, et al.. (2017). Development of persistent gastrointestinal S. aureus carriage in mice. Scientific Reports. 7(1). 12415–12415. 8 indexed citations
12.
Marcus, Katrin, et al.. (2017). Hsp90-downregulation influences the heat-shock response, innate immune response and onset of oocyte development in nematodes. PLoS ONE. 12(10). e0186386–e0186386. 15 indexed citations
13.
Lindemann, Claudia, et al.. (2017). Strategies in relative and absolute quantitative mass spectrometry based proteomics. Biological Chemistry. 398(5-6). 687–699. 64 indexed citations
14.
Allen, Elizabeth, Pauline M. van Diemen, Yuko Yamaguchi, et al.. (2016). MRI Based Localisation and Quantification of Abscesses following Experimental S. aureus Intravenous Challenge: Application to Vaccine Evaluation. PLoS ONE. 11(5). e0154705–e0154705. 2 indexed citations
15.
Flaxman, Amy, Elizabeth Allen, Claudia Lindemann, et al.. (2016). Risk factors for dermatitis in submariners during a submerged patrol: an observational cohort study. BMJ Open. 6(6). e010975–e010975. 1 indexed citations
16.
Drazic, Adrian, Daniel A. Rutz, Thomas Kriehuber, et al.. (2015). The activity of protein phosphatase 5 towards native clients is modulated by the middle- and C-terminal domains of Hsp90. Scientific Reports. 5(1). 17058–17058. 26 indexed citations
17.
Lindemann, Claudia, Alexandra Müller, Bettina Warscheid, et al.. (2013). Redox Proteomics Uncovers Peroxynitrite-sensitive Proteins That Help Escherichia coli to Overcome Nitrosative Stress. Journal of Biological Chemistry. 288(27). 19698–19714. 23 indexed citations
18.
Lindemann, Claudia & Lars I. Leichert. (2012). Quantitative Redox Proteomics: The NOxICAT Method. Methods in molecular biology. 893. 387–403. 27 indexed citations
19.
Lindemann, Claudia, et al.. (2011). A phosphoarginine containing peptide as an artificial SH2 ligand. Chemical Communications. 47(37). 10335–10335. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenguang Shao Breakdown of academic impact, for papers by Christien Kluwe Breakdown of academic impact, for papers by Delphine Flatters Breakdown of academic impact, for papers by Thomas Hesson Breakdown of academic impact, for papers by Agnès M. Jaulent Breakdown of academic impact, for papers by Halina Mikolajek Breakdown of academic impact, for papers by Binghua Shen Breakdown of academic impact, for papers by Max V. Ranall Breakdown of academic impact, for papers by Sayantani Chatterjee
Rankless by CCL
2026